Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 8/20 | 0.57 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | APAF1 | O14727 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7933277 | 0.83 | SLC9A1 (0.57) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL4919614 | 0.83 | SLC9A1 (0.57) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL283984 | 0.83 | SLC9A1 (0.65) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL7848235 | 0.80 | SLC9A1 (0.53) | SLC9A1GRM2RAB9ANPC1APAF1 | |
| SCHEMBL31483490 | 0.79 | SLC9A1 (0.63) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL4154129 | 0.78 | SLC9A1 (0.59) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL31483489 | 0.78 | SLC9A1 (0.61) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL284672 | 0.77 | SLC9A1 (0.66) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL9140982 | 0.76 | SLC9A1 (0.56) | SLC9A1RAB9ANPC1MAPTAPAF1 | |
| SCHEMBL3675871 | 0.76 | SLC9A1 (0.59) | SLC9A1GRM2RAB9ANPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689028-A1 | LUBRICANT ADDITIVE COMPOSITION FOR ELECTRIC VEHICLE | The Lubrizol Corporation (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2025216922-A1 | BORON CONTAINING AUTOMOTIVE GEAR OIL | THE LUBRIZOL CORPORATION (US) | 2025-10-16 | — | — | WO | disclosed |
| WO-2024206581-A1 | LUBRICANT ADDITIVE COMPOSITION FOR ELECTRIC VEHICLE | THE LUBRIZOL CORPORATION (US) | 2024-10-03 | — | — | WO | disclosed |
| US-9023860-B2 | Pro-drugs for controlled release of biologically active compounds | SIGNATURE THERAPEUTICS, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9023860-B2 | Pro-drugs for controlled release of biologically active compounds | SIGNATURE THERAPEUTICS, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-20150045263-A1 | Lubricating Composition | LUBRIZOL CORP (US) | 2015-02-12 | — | — | US | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
| US-20100160191-A1 | Lubricating Composition | THE LUBRIZOL CORPORATION (US) | 2010-06-24 | — | — | US | disclosed |
| US-20090137618-A1 | PRO-DRUGS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 3I, LP | 2009-05-28 | — | — | US | disclosed |
| US-20090137618-A1 | PRO-DRUGS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 3I, LP | 2009-05-28 | — | — | US | disclosed |
| US-20090093384-A1 | Lubricants That Decrease Micropitting for Industrial Gears | THE LUBRIZOL CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137618-A1 | PRO-DRUGS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | CRH, FURIN, PEPD | SLC9A1 2833/4885GRM2 2722/4885RAB9A 707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.